sildenafil

Generic: sildenafil

Labeler: actavis pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sildenafil
Generic Name sildenafil
Labeler actavis pharma, inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

sildenafil citrate 10 mg/mL

Manufacturer
Actavis Pharma, Inc.

Identifiers & Regulatory

Product NDC 0591-4050
Product ID 0591-4050_4c7d4ea0-d3b7-4a20-b5d6-09207153aaad
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211534
Listing Expiration 2026-12-31
Marketing Start 2020-08-17

Pharmacologic Class

Classes
phosphodiesterase 5 inhibitor [epc] phosphodiesterase 5 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05914050
Hyphenated Format 0591-4050

Supplemental Identifiers

RxCUI
1307427
UNII
BW9B0ZE037

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sildenafil (source: ndc)
Generic Name sildenafil (source: ndc)
Application Number ANDA211534 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (0591-4050-94) / 112 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

sildenafil citrate (10 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4c7d4ea0-d3b7-4a20-b5d6-09207153aaad", "openfda": {"unii": ["BW9B0ZE037"], "rxcui": ["1307427"], "spl_set_id": ["0e6428c0-e0e9-4fc0-8615-6a9678d2286c"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0591-4050-94)  / 112 mL in 1 BOTTLE", "package_ndc": "0591-4050-94", "marketing_start_date": "20200817"}], "brand_name": "Sildenafil", "product_id": "0591-4050_4c7d4ea0-d3b7-4a20-b5d6-09207153aaad", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "0591-4050", "generic_name": "Sildenafil", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sildenafil", "active_ingredients": [{"name": "SILDENAFIL CITRATE", "strength": "10 mg/mL"}], "application_number": "ANDA211534", "marketing_category": "ANDA", "marketing_start_date": "20200817", "listing_expiration_date": "20261231"}